Clinical trial
Investigation on the Prognostic Value of Biochemical Markers in the Cerebrospinal Fluid for the Functional Outcome of Spinal Cord Injured Patients
NCT01861808 is registered in ClinicalTrials.gov with Azienda Usl di Bologna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation on the Prognostic Value of Biochemical Markers in the Cerebrospinal Fluid for the Functional Outcome of Spinal Cord Injured Patients
- Lead sponsor
- Azienda Usl di Bologna
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 24, 2013
- Completion date
- August 31, 2017
- Enrollment
- 10 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.